Evidence map›Paper›PMID 12409614›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Expression of human epileptic temporal lobe neurotransmitter receptors in Xenopus oocytes: An innovative approach to study epilepsy.

Eleonora Palma, Vincenzo Esposito, Anna Maria Mileo, Giancarlo Di Gennaro, Pierpaolo Quarato, Felice Giangaspero, Ciriaco Scoppetta, Paolo Onorati, Flavia Trettel, Ricardo Miledi and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. GABAScientific reports · 2022
    Article
  6. Article
  7. Article
  8. Mammalian Brain CaMembranes · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Physiological characterization of human muscle acetylcholine receptors from ALS patients.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  17. Article
  18. Microtransplantation of neurotransmitter receptors from postmortem autistic brains to Xenopus oocytes.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  19. GABA(A)-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABA(A) "phasic" receptors.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  20. Abnormal GABAA receptors from the human epileptic hippocampal subiculum microtransplanted to Xenopus oocytes.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Eleonora PalmaIstituto Pasteur-Fondazione Cenci Bolognetti and Dipartimento di Fisiologia Umana e Farmacologia, Universita' di Roma La Sapienza, Piazzale A. Moro 5, Italy.
Vincenzo Esposito
Anna Maria Mileo
Giancarlo Di Gennaro
Pierpaolo Quarato
Felice Giangaspero
Ciriaco Scoppetta
Paolo Onorati
Flavia Trettel
Ricardo Miledi
Fabrizio Eusebi
Istituto Pasteur · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poly(A(+)) RNA was extracted from the temporal lobe (TL) of medically intractable epileptic patients which underwent surgical TL resection. Injection of this mRNA into Xenopus oocytes led to the expression of ionotropic receptors for gamma-aminobutyric acid (GABA), kainate (KAI) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). Membrane currents elicited by GABA inverted polarity at -15 mV, close to the oocyte's chloride equilibrium potential, were inhibited by bicuculline, and were potentiated by pentobarbital and flunitrazepam. These basic characteristics were also displayed by GABA currents elicited in oocytes injected with mRNAs isolated from human TL glioma (TLG) or from mouse TL. However, the GABA receptors expressed by the epileptic TL mRNA exhibited some unusual properties, consisting in a rapid current run-down after repetitive GABA applications and a large EC(50) (125 microM). AMPA alone evoked very small or nil currents, whereas KAI induced larger currents. Nevertheless, upon cyclothiazide treatment, AMPA elicited substantial currents that, like the KAI currents, were inhibited by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). Furthermore, the glutamate receptor 5 (GluR5) agonist, ATPA, failed to evoke an obvious current although both RT-PCR and Western blot analyses showed GluR5 expression in the epileptic TL. Oocytes injected with mouse TL or human TLG mRNAs generated KAI and AMPA currents similar to those evoked in oocytes injected with epileptic TL mRNA but, in contrast to these, the mouse TL and human TLG oocytes were also responsive to ATPA. Our findings are in accord with the concept that both a depression of GABA inhibition and a dysfunction of the KAI-receptor system maintain a high neuronal excitability that results in epileptic seizures.

Indexed as

6-Cyano-7-nitroquinoxaline-2,3-dioneAdolescentAdultalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidAnimalsBicucullineEpilepsy, Temporal LobeFemalegamma-Aminobutyric AcidHumansMaleMembrane PotentialsOocytesReceptors, NeurotransmitterReverse Transcriptase Polymerase Chain ReactionRNA, Messenger6-Cyano-7-nitroquinoxaline-2,3-dionealpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic AcidBicucullinegamma-Aminobutyric AcidReceptors, NeurotransmitterRNA, Messenger

Identifiers

PMID12409614
PMCPMC137546
OpenAlexW2057300543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.